News and Blog

News and Blog
News

Date:
08-09-13

Author:
Empower

Empower: Access to Medicine supports the Medical Innovation Bill

Empower: Access to Medicine supports the Medical Innovation Bill

On Wednesday 11th September Michael Ellis MP will introduce the Medical Innovation Bill to the House of Commons, supported by Lord Saatchi, the Bill calls for doctors to be given more space to innovate responsibly.

The Empower Access to Medicine campaign has been following the Bill closely and working with the team to support its objectives, as they are very much aligned with our own. Though the motives behind the Bill are largely focussed on the treatment of cancer, the implications of the Bill have wider consequences for a great many conditions.

Coinciding with the Bill reaching the House of Commons, the Empower campaign will release its maiden policy report – that addresses many of the themes in the Medical Innovation Bill.

Empower: Access to Medicine founder, Les Halpin, welcomes the Medical Innovation Bill being discussed in the House of Commons next week;

“This Bill is an excellent vehicle for driving patient access to medicines further up the political agenda. For too long the drug development process has been allowed to continue unchanged and unchallenged.

“Developing a drug is expensive, complicated and too reliant on the individual drive of a small number of patients and doctors. People with life-threatening conditions are given few options to take drugs that have shown promise at an early stage.

“I hope the Bill put forward by Michael Ellis MP with the support of Lord Saatchi, in conjunction with Empower’s first policy report published this week, will put this important issue back on the table of policy makers and medical professionals.”

Comments

    Add your comment

    Please enter the word you see in the image below:


    Categories

    Recent Articles

    Latest Tweets

    Press Enquiries

    Please contact James Hargrave at JBP PR or telephone 0203 267 0074 for any press or event related enquiries.